期刊文献+

不同剂量氟伐他汀治疗老年冠心病的效果及对患者TNF-α、MCP-1、IL-18及血液流变学的影响 被引量:2

Effect of different doses of fluvastatin in the treatment of elderly patients with coronary heart disease and its influence on TNF-α,MCP-1,IL-18 and hemorheology
下载PDF
导出
摘要 目的分析不同剂量氟伐他汀治疗老年冠心病的效果及对患者肿瘤坏死因子α(TNF-α)、单核细胞趋化蛋白-1(MCP-1)、白细胞介素18(IL-18)及血液流变学的影响。方法选取我院2018年1月至2019年12月收治的100例老年冠心病患者作为研究对象,采用随机数字表法将其分为对照组和观察组,各50例。两组均采用氟伐他汀治疗,对照组40 mg/d,观察组80 mg/d。比较两组的临床疗效、炎症因子水平及血液流变学指标。结果观察组治疗总有效率高于对照组,但差异无统计学意义(P>0.05)。治疗后,两组TNF-α、MCP-1、IL-18水平均低于治疗前,且观察组低于对照组(P<0.05)。治疗后,两组血浆粘度、纤维蛋白、红细胞压积均低于治疗前,且观察组低于对照组(P<0.05)。结论相较于氟伐他汀40 mg/d,80 mg/d更能改善老年冠心病患者的临床症状和体征,且有助于抑制炎性因子的过度表达,改善患者血液流变学。 Objective To analyze the effect of different doses of fluvastatin in the treatment of elderly patients with coronary heart disease and its influence on tumor necrosis factor-α(TNF-α),monocyte chemoattractant protein-1(MCP-1),interleukin-18(IL-18)and hemorheology.Methods A total of 100 elderly patients with coronary heart disease in our hospital from January 2018 to December 2019 were selected as the research objects,and the patients were divided into control group and observation group by random number table method,with 50 cases in each group.Both groups were treated with fluvastatin,40 mg/d in the control group and 80 mg/d in the observation group.The clinical efficacy,inflammatory factor levels and hemorheology indexes of the two groups were compared.Results The total effective rate of the observation group was higher than that of the control group,but the difference was not statistically significant(P>0.05).After treatment,the levels of TNF-α,MCP-1 and IL-18 of the two groups were lower than those before treatment,and those of the observation group were lower than the control group(P<0.05).After treatment,the plasma viscosity,fibrin and hematocrit of the two groups were lower than those before treatment,and those of the observation group was lower than the control group(P<0.05).Conclusion Compared with fluvastatin 40 mg/d,80 mg/d can improve the clinical symptoms and signs of elderly patients with coronary heart disease,and it is helpful to inhibit the overexpression of inflammatory factors and improve the hemorheology of patients.
作者 杨永秀 赵锋 YANG Yongxiu;ZHAO Feng(Xi'an Gaoxin Hospital,Xi'an 710075;the Third Affiliated Hospital of Xi'an Medical University,Xi'an 710068,China)
出处 《临床医学研究与实践》 2021年第8期65-67,共3页 Clinical Research and Practice
关键词 冠心病 氟伐他汀 剂量 炎症因子 血液流变学 coronary heart disease fluvastatin dosage inflammatory factors hemorheology
  • 相关文献

参考文献10

二级参考文献69

  • 1齐晓勇,谷剑,李树仁,李俊勇,党义,王天红,张建清,李英肖,靳福昌,郜利会.冠心病患者介入治疗前后血浆白细胞介素-8变化与早期并发症的关系[J].临床心血管病杂志,2004,20(6):334-336. 被引量:7
  • 2程荣超,崔林.肺炎衣原体抗体与冠心病及血脂关系的研究[J].中国老年学杂志,2005,25(9):1130-1131. 被引量:5
  • 3贾兴旺,田亚平,郭广宏.血清12项细胞因子在冠心病诊断中的应用价值[J].中华检验医学杂志,2006,29(9):830-833. 被引量:12
  • 4WHO.缺血性心肌病的命名及诊断标准[J].中华心血管病杂志,1981,9(1):75-75. 被引量:9
  • 5中华心血管病杂志编辑委员会血脂异常防治对策专题组.血脂异常防治建议.中华心血管病杂志,2002,30(11):643-646. 被引量:5
  • 6Sachs FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events Mter myocardial infarction in patients with average cholesterol levels, N Engl J Med, 1996,335 : 1001-1009. 被引量:1
  • 7Pedersen TR,Kjekshus J, Bcrg K, et at, Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study(4S). Lancet, 1995,345:1274- 1277. 被引量:1
  • 8Rosenson RS, Tangney CC Antiatherothrombolic properties of statins, Implications for cardiovascular events reduction. JAMA, 1998,279 : 1643-1650. 被引量:1
  • 9Berk B, Weintraub WS, Alexander RW, et al. Elevation of C-reactive protein in "Active" coronary artery disease. Am J Cardiol.1990,65:168-172. 被引量:1
  • 10Peter Boekstegers,Iris Kainz,Wolfgang Giehrl,Wolfgang Peter,Karl Werdan. Subchronic exposure of cardiomyocytes to low concentrations of tumor necrosis factor α attenuates the positive inotropic response not only to catecholamines but also to cardiac glycosides and high calcium concentrations[J] 1996,Molecular and Cellular Biochemistry(2):135~143 被引量:1

共引文献100

同被引文献34

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部